| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193788 | Annals of Allergy, Asthma & Immunology | 2006 | 7 Pages |
Abstract
Results from this study indicate that 100-μg and 200-μg daily doses of ciclesonide are effective in the treatment of SAR. Ciclesonide, 200 μg/d, appears to be the optimal dose studied for reducing the symptoms of SAR while maintaining an acceptable safety profile.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Paul H. MD, Mark A. PhD, Julius H. MD, Frank MD, Patrick F. PhD, Stefan PhD, Sheldon PhD, Tushar MD,